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ABSTRACT 
Members of the class Mollicutes are unique among bacteria in that they are unable to 
synthesize a cell wall. These organisms are also difficult to culture and very slow-growing with 
some species requiring up to 40 days to culture. Many of these bacteria are also significant 
pathogens in humans and animals, so rapid identification of isolates is a necessary diagnostic 
step. Many different tests are used for identification of pathogenic Mollicutes (primarily 
Mycoplasma and Ureaplasma species), however most tests are not cost or time efficient. Two 
relatively recent diagnostic tools are matrix-assisted laser desorption/ionization time-of-flight 
(MALDI-TOF) mass spectrometry and high-resolution melting polymerase chain reaction 
(HRM-PCR). Nine isolates of Mycoplasma bovis, a pathogen in cattle, were grown and used first 
in a MALDI-TOF assay and then in an HRM-PCR assay utilizing universal primers for the 16S-
23S rRNA intergenic spacer region (IGSR) of Mycoplasma species. The HRM-PCR assay 
compared the melt curve profile of the control isolate to the other eight for species determination. 
Both assays were able to successfully identify all nine isolates. Next, a new HRM-PCR assay 
also targeting the 16S-23S rRNA IGSR was developed and compared to the original assay. 
Reference and field strains of six Mycoplasma species were cultured along with reference strains 
for two additional Mycoplasma species and one Ureaplasma species. All of these isolates were 
tested in both the first (HRM-PCR-1) and second (HRM-PCR-2) HRM assay, and melt curve 
profiles of the field isolates were compared to the controls for identification. HRM-PCR-1 failed 
to amplify Mycoplasma gallisepticum and Ureaplasma diversum and was unable to identify the 
majority of Mycoplasma hyorhinis and Mycoplasma hyosynoviae isolates. HRM-PCR-2 
identified the majority of M. hyorhinis and all Mycoplasma canis isolates, but failed to identify 
M. gallisepticum. All isolates of Mycoplasma bovis and Mycoplasma hyopneumoniae were 
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successfully identified in both methods. HRM-PCR is a promising tool for identification, but 
more validation is necessary to provide consistent and accurate results. Future work should focus 
on expanding the MALDI-TOF database and testing different species in the HRM-PCR assays. 
Additionally, the use of HRM-PCR directly on tissue samples should be explored. 
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CHAPTER 1: THESIS ORGANIZATION 
This thesis is organized into five chapters. Chapter 1 contains the outline of the thesis. 
Chapter 2 reviews general information about the class Mollicutes, its significance, and diagnostic 
methods that are used with these organisms. Chapter 3 contains research comparing a MALDI-
TOF assay to a high-resolution melting PCR assay for Mycoplasma species identification. 
Chapter 4 also contains research, comparing two high-resolution melting PCR assays for the 
identification of Mycoplasma species. Chapter 5 serves as a general conclusion. 
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CHAPTER 2: REVIEW OF THE MOLLICUTES AND DIAGNOSTIC 
METHODS 
 
Introduction 
Members of the class Mollicutes are among the smallest free-living organisms, with 
diameters as small as 0.3 μm. Mollicutes have a variety of distinctive features such as their small 
genomes, the low guanine (G) and cytosine (C) content of their genomes and their fastidious 
nature (Razin, 1983). These organisms are thought to be derived from Gram-positive bacteria, 
and through extensive genomic reduction have developed their most significant feature: the 
complete lack of a cell wall (Razin et al., 1998). 
Members of the Mollicutes are known for not only being some of the smallest free-living 
organisms in diameter, but also in genome size. For example, Mycoplasma genitalium has a 
genome of only 580,070 bp (Fraser et al., 1995). Ureaplasma parvum has a genome size of only 
727,289 bp (Wu et al., 2014). In contrast, E. coli K-12 has a genome size of 4,639,221 bp, 
approximately 8 times larger than that of M. genitalium (Blattner et al., 1997). The genomes of 
Mollicutes differ from conventional bacteria not only in size but also in composition. The GC-
content of E. coli K-12 is 50.8% (Blattner et al., 1997), while that of M. genitalium is 32% 
(Fraser et al., 1995) and that of U. parvum is 25.6% (Wu et al., 2014). This lower G+C-content is 
characteristic of the Mollicutes. The G+C-content of a bacterium is reflective of its capabilities 
as an organism. In general, G+C-content is directly correlated with genome size and the 
organism’s adaptability, with a higher genome size and G+C-content typically exhibiting a 
greater ability to adapt to different environments (Mann and Chen, 2010). As these organisms are 
generally host-specific and fastidious, their small genomes and low GC-content are consistent 
with this observation. 
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Mollicutes lack a large portion of biochemical processes that other bacteria possess. For 
example, Mycoplasma hyopneumoniae, Mycoplasma synoviae, and Mycoplasma mycoides lack 
the capabilities for de novo nucleotide synthesis (Mitchell and Finch, 1977; Arraes et al., 2007). 
Additionally, M. synoviae is one of the few Mollicutes capable of converting citrate to acetate 
and oxaloacetate, a step in the reductive TCA cycle, and not a single amino acid is synthesized 
by M. hyopneumoniae (Arraes et al., 2007). Because of these and additional biochemical 
deficiencies, Mollicutes are generally quite fastidious. Culturing Mycoplasma species and other 
members of the Mollicutes is a tedious and difficult process. Sterol is required for the growth of 
most Mollicutes, and so complex media containing animal serum is utilized (Rodwell and Abbot, 
1961). Culturing times vary, but can take anywhere from 3 to 40 days depending on the species 
(Lauerman, 1994; Jensen et al., 1996). 
Another common feature of the Mollicutes is the fried-egg morphology of colonies when 
grown on solid media. The colonies have a central area in which the cells grow into the agar with 
a peripheral zone that spreads out along the surface of the agar, resulting in a colony that 
resembles a fried egg (Razin and Oliver, 1961). This is not unique to the Mollicutes, however. L-
forms of bacteria are phases in which the cells produce either a partial or no cell wall, and many 
bacteria are capable of exhibiting an L-form. (Glover et al., 2009). When these L-forms are 
grown on agar plates, they can also exhibit a fried-egg morphology, and the L-form of a 
bacterium can be induced by the introduction of antibiotics such as penicillin and other β-lactams 
(Razin and Oliver, 1961). These antimicrobials are frequently used in the culturing of Mollicutes 
because they will prevent the growth of conventional bacteria while allowing Mollicutes to grow 
as they lack the cell wall targets of these antibiotics. This creates a challenge when attempting to 
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grow and identify species within the Mollicutes, as an L-form can be mistaken as a Mycoplasma 
species. 
Diagnostic Needs 
Veterinary Pathogens 
Identifying species of Mollicutes is necessary for diagnostics, as many are human, 
animal, and plant pathogens. In human and animal hosts, Mollicutes tend to colonize the mucosal 
areas of the body including the respiratory tract and the urogenital tract (Trachtenberg, 2005). 
These bacteria can exist as commensals, but more frequently they are pathogens in their hosts 
(Razin, 1983). As animal pathogens, Mycoplasma species collectively cause a variety of diseases 
such as pneumonia, arthritis, conjunctivitis, mastitis, otitis media, and hemolytic anemia 
(Lauerman, 1994; Wang et al., 2017). Usually these infections are not severe, but they increase 
the risk of additional infections or severity of disease in co-infected animals (Staugas and Martin, 
1985; Thacker et al., 1999). Ureaplasma species are also known to cause disease in animals. 
These infections occur in the urogenital tract and can cause abortions, infertility, and 
endometritis (Ruhnke, 1994; Waites et al., 2005). 
As previously stated, Mycoplasma and Ureaplasma species are veterinary pathogens, and 
can cause various diseases. In swine, for example, M. hyopneumoniae is known to cause porcine 
enzootic pneumonia which has low mortality but high morbidity in infected animals. The disease 
causes depletion of the ciliated epithelial cells of the lower respiratory tract and is 
immunomodulatory, increasing the susceptibility of the pigs to secondary infections (DeBey and 
Ross, 1994). Secondary infections are also more common in infections with hemotropic 
Mycoplasma species. While originally thought to be unrelated, these blood parasites were 
discovered to be members of the Mollicutes after the emergence of better molecular tools for 
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phylogenetic analyses (Messick, 2004). One such hemotropic organism is Mycoplasma ovis. This 
bacterium infects small ruminants such as sheep and goats and usually causes a latent infection. 
Infected animals will become more prone to secondary infections with other bacterial pathogens, 
however, increasing the risk of severe disease (Rjeibi et al., 2015). Mycoplasma canis is a 
common commensal in dogs, but it is also an opportunistic pathogen of the urogenital tract, 
causing urinary tract infections, prostatitis, and other infections (L'Abee-Lund et al., 2003). An 
association has also been shown between the presence of M. canis in canine brain tissues and 
granulomatous meningoencephalitis or necrotizing meningoencephalitis, conditions that cause 
seizures, blindness, and often death (Michaels et al., 2016). In cattle, Ureaplasma diversum can 
complicate breeding practices. When infected, cows may become infertile or undergo 
spontaneous abortions. Calves that are born from infected cows may develop weak-calf 
syndrome, often resulting in a weakened immune system and low birth weight (Takasu et al., 
2008). 
Human Pathogens 
There are also significant human pathogens among the Mollicutes. Mycoplasma 
pneumoniae is the etiological agent of primary atypical pneumonia in humans, and can cause 
otitis media, pharyngitis and the formation of abscesses as well (Atkinson et al., 2008). In 
addition to pneumonia, M. pneumoniae has also been identified as a risk factor for asthma in 
patients with a chronic infection (Sutherland et al., 2004). Also pathogenic in humans is M. 
genitalium. This organism can be sexually-transmitted and causes urethritis in men and 
cervicitis, infertility, and pelvic inflammatory disease in women (Manhart, 2017). 
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Cell Culture Contaminants 
In cell culture, Mollicutes such as Mycoplasma and Acholeplasma species are among the 
most frequent contaminants. Based on routine testing from the 1970s to 1994, up to 15% of all 
cell cultures in the United States may be contaminated with Mollicutes at any given time (Ryan, 
2008). There are multiple sources from which the contaminant may be introduced; cells from the 
persons handling the cultures, the serum used in the cell culture media, and use of improperly 
sterilized tools are all suggested origins (Drexler and Uphoff, 2002). While antibiotics are 
frequently used in cell culture, they may not always help as any β-lactam antibiotics will have no 
effect on the Mollicutes. 
The effects that Mollicutes have on cell cultures depend heavily on the metabolic 
capabilities of the contaminant, and so can vary greatly. Mycoplasma gallisepticum can induce 
plaque formation in cell monolayers similar to those of viral agents, making it difficult to 
determine if a there truly is a contaminant when growing viruses. Additionally, the cytopathic 
effects of the contaminant may be severe or unapparent, or may decrease or increase viral yields 
(Barile and Grabowski, 1978). Because of the unpredictable effects of Mycoplasma and 
Acholeplasma contaminants, rigorous testing is necessary to ensure the purity of cell cultures. 
Economic and Ecological Impact 
Mycoplasma and Ureaplasma species cause many different kinds of infections in a 
variety of hosts and can be extremely costly to the animal industry. In 2014 it was estimated that 
infections of M. hyopneumoniae cost the United States’ swine industry up to $400 million each 
year (Holtkamp, 2014). Two other species, Mycoplasma hyorhinis and Mycoplasma 
hyosynoviae, are also known to cause disease in swine and contribute to up to 43% of all losses 
due to lameness in pigs (Wilberts et al., 2015). Cattle can also experience mycoplasma 
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infections. Mycoplasma bovis causes respiratory disease, mastitis, and arthritis in cattle and 
causes annual losses of up to $32 million to the beef industry and $108 million to the dairy 
industry (Maunsell et al., 2011). In the poultry industry, M. gallisepticum causes chronic 
respiratory disease and has been shown to decrease weight gain and production in egg layers. A 
1987 study showed a total loss of approximately $7.3 million to egg producers in southern 
California (Mohammed et al., 1987). Mycoplasma gallisepticum infections are still a problem 
today, though to the authors’ knowledge no recent studies on its economic impact have been 
conducted. 
Mycoplasma infections are not just a problem in agriculture but are also a problem for 
wildlife. Mycoplasma gallisepticum, long-considered a pathogen in chickens and turkeys, also 
causes disease in songbirds. It emerged as a significant pathogen of the house finch in 1994 and 
is now known to cause severe conjunctivitis in these birds (Luttrell et al., 1998). In fact, within 
three years after it was first identified, M. gallisepticum devastated house finch populations, 
causing a decline of up to 60% in the eastern United States (Badyaev, 2012). 
Identification and Characterization Methods 
Because Mycoplasma and Ureaplasma species are significant pathogens and cell culture 
contaminants, methods of identification are vital for diagnostic purposes. There are many 
different identification methods used for these organisms, from traditional biochemical or 
serological tests to more recent molecular methods such as polymerase chain reaction (PCR). 
Biochemical and Serological Tests 
As previously stated, when grown on agar, most members of the Mollicutes form a 
distinct fried-egg colony morphology (Razin and Oliver, 1961). Monitoring the growth of a 
suspect Mycoplasma or Ureaplasma species and looking for the correct colony morphology may 
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be sufficient to identify the organism as a member of the Mollicutes. However since L-forms of 
bacteria can also form this same morphology, confirmation is essential to ensure that a 
Mollicutes suspect is not an L-form. L-forms will revert back to their cell walled form 
eventually, so a series of five passages in media without an antibiotic is considered sufficient to 
rule them out (Goll, 1994). 
Once a culture is obtained and confirmed as a member of the Mollicutes, there are 
numerous biochemical tests that can be performed to identify the species isolated. Glucose 
fermentation, a vital first test for ruling out a large percentage of Mycoplasma suspects, can be 
determined through the use of a pH indicator in the media. When the bacterium is able to ferment 
glucose, the media will become more acidic, resulting in a lower pH and subsequent change in 
the media color (Goll, 1994). An arginine test is another important tool for identifying Mollicutes 
biochemically, as most of the Mycoplasma species that are not able to ferment glucose are able 
to hydrolyze arginine (Goll, 1994). To differentiate a Mycoplasma species from a Ureaplasma 
species, two different media can be used when culturing: one with added urea and one without, 
as Ureaplasma species require urea to grow (Shepard, 1983). After these tests are complete, 
further biochemical media can be used to determine the species. 
Multiple kinds of serological tests can also be used to identify Mollicutes. If a certain 
species is suspected of causing disease in an animal, culture can be done in duplicate with one set 
of media containing antisera to the suspect organism. Growth in the absence of antisera but not 
in the presence in theory confirms the identity of the organism. This is referred to as a growth 
inhibition test. In practice, however, inaccurate identification can occur due to cross-reactivity of 
the antibodies (Clyde, 1964). A second type of serological test is one utilizing 
immunofluorescence. For this assay, fluorescently labeled antibodies to a certain organism are 
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used. A fluorescent signal, when viewed with a fluorescent microscope, is considered positive 
for the organism of interest (Del Giudice et al., 1967). A third serological test is 
immunohistochemistry (IHC) in which a culture of the suspect organism is not needed. Instead, 
the antibodies are applied directly to the tissue and visualized under a microscope through the 
use of a tag, often streptavidin-biotin, and a fluorescent probe (Opriessnig et al., 2004). 
Molecular Diagnostic Tests 
While biochemical tests are considered the gold standard, they require multiple cultures 
to assess, and can take weeks to complete. Serological tests can be very sensitive, but 
maintaining antibodies specific to every Mycoplasma species that might be grown in a diagnostic 
laboratory is very expensive. To overcome some of these barriers, PCR assays have been 
developed for Mollicutes, and these are rapid and relatively inexpensive. These tests target 
specific regions of DNA and do not need to be used on a bacterial culture (Yang and Rothman, 
2004). Conventional PCR targets a specific region of DNA and, after amplification, the product 
is detected through agarose gel electrophoresis. If an appropriately-sized band is present, then the 
tissue sample or culture is considered positive (Yang and Rothman, 2004). For Mollicutes, PCR 
assays frequently target the 16S rRNA genes of the organisms but may target other regions of the 
chromosome as well (Robertson et al., 1993; Chavez Gonzalez et al., 1995; Jensen et al., 2003). 
Real-time PCR (qPCR) targets a much smaller region of DNA than conventional PCR 
and utilizes a fluorophore in the PCR reaction which eliminates a subsequent detection step. If 
the amount of fluorescence reaches a certain level, the sample is considered positive for the 
organism of interest. If quantitation of the organism is desired, serial dilutions of a standard with 
a known quantity of DNA can be used to generate a standard curve from which quantities in an 
unknown sample can be calculated. Two main types of qPCR exist: those using hybridization 
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probes and those using DNA intercalating dyes. The former assays use a short oligonucleotide 
probe containing a fluorophore in addition to forward and reverse primers. When the probe is 
degraded during the assay as a function of the DNA polymerase, the fluorophore is released and 
emits light (Holland et al., 1991). Fluorescent dyes that intercalate into DNA are also used for 
qPCR. These are more prone to false positives than hybridization probe assays, but are also less 
expensive because specific probes are not needed (Ponchel et al., 2003). If a melt step follows 
the qPCR, specificity can be improved by comparing the melting temperature (TM) of the 
positive control to the sample (Downey, 2015). Both types of real-time PCR assays have been 
used for detection of Mycoplasma and Ureaplasma species (Dubosson et al., 2004; Xiao et al., 
2010; Gomes Neto et al., 2015). 
Molecular Characterization 
In addition to identification, characterization methods are often used with Mycoplasma 
species during the diagnostic process. Two common tools used today for molecular 
characterization of Mycoplasma species are multi-locus sequence typing (MLST) and multiple 
locus variable-number tandem repeat analysis (MLVA). One major use of these typing tools is 
for molecular epidemiology. By following the movement of similar strains, producers can locate 
the source of an outbreak and implement measures for minimizing or preventing outbreaks in the 
future. 
In MLST, between three and seven genes are characterized. Typically housekeeping 
genes are used, as these mutate very slowly and so are better candidates for strain typing 
(Maiden, 2006). After performing PCR on the selected genes, the products are sequenced, and 
the different isolates are classified based on the various combinations of the different sequences. 
One major downfall of this type of assay is that the sequence types are completely dependent on 
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the targets used, so to compare isolates, the exact same typing scheme must be used. To improve 
the universal utilization of these assays, the database PubMLST is available to share typing 
schemes globally, and as of 2018, schemes for seven different Mycoplasma species have been 
uploaded (Oxford). Additionally, MLST relies on the presence of polymorphisms in 
housekeeping genes, but not all organisms will have a sufficient amount of these to make such an 
assay meaningful, such as has been observed with M. pneumoniae (Degrange et al., 2009). In this 
case, other typing methods must be used. 
MLVA is a typing scheme that is similar to MLST in some aspects but has a few distinct 
differences. This assay uses the presence of tandem repeats in the genome to type bacteria. As 
with MLST, a few gene targets are chosen based on their level of variation. The type for MLVA, 
however, is dependent on the number of tandem repeats in the given targets and not the exact 
sequence (Vergnaud and Pourcel, 2006). Since the sequences are not needed, this method is less 
expensive than MLST, as the number of repeats can be determined based on the size of the PCR 
products. MLVA still has its drawbacks, however, as the exact same typing scheme must be used 
to compare isolates as with MLST. 
Emerging Tools for Identification and Characterization 
High-resolution melting PCR 
With the appropriate instruments and PCR reagents, additional information can be 
obtained in a high-resolution melting (HRM) analysis, an emerging diagnostic tool. Following a 
real-time PCR assay which incorporates an intercalating dye, a step can be added in which the 
DNA is slowly melted to determine the exact melting point of the strand. When the instrument 
reaches the TM of the PCR product, the two strands of DNA will separate, releasing the dye. This 
temperature is constant for a given DNA sequence and is determined by its size and GC-content. 
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For HRM-PCR, instruments with improved temperature specificity and stability are needed 
along with specific fluorescent dyes without intercalation bias (Taylor et al., 2010). HRM is a 
very powerful tool that was originally used to distinguish between heterozygotes and 
homozygotes of a gene (Gundry et al., 2003). Now, the uses of HRM have expanded to include 
detection of single nucleotide polymorphisms, of DNA methylation, and antibiotic resistance 
markers as well as genotyping (Tamburro and Ripabelli, 2017). HRM has also been used for 
bacterial identification and differentiation (Winchell et al., 2010). 
HRM has been used in this regard for Mycoplasma species as well. Two Mycoplasma 
species that affect poultry, M. gallisepticum and M. synoviae, have temperature sensitive vaccine 
strains, but often these are difficult to distinguish from pathogenic field strains. HRM-PCR has 
been used to rapidly distinguish between field strains and vaccine strains of these organisms, 
improving flock status determination (Ghorashi et al., 2013; Shahid et al., 2014). Differentiation 
between strains of the same Mycoplasma species has also been done, distinguishing temperature 
sensitive, non-temperature sensitive, and field strains of M. gallisepticum (Ghorashi et al., 2010). 
HRM has also been used to detect a mixed population of M. gallisepticum. A 2015 study showed 
that an HRM-PCR assay was able to detect two different strains of M. gallisepticum in the same 
sample at varying concentration ratios (Ghorashi et al., 2015). Lastly, HRM has been used as a 
tool for identification of unknown Mycoplasma species using a set of universal primers (Rebelo 
et al., 2011). This study was limited to isolates of ruminant, avian, and canine origin, but showed 
the broad application yet specific capabilities of HRM-PCR with Mycoplasma species. 
MALDI-TOF Mass Spectrometry 
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry is a relatively recent technology that has become a widespread diagnostic tool. 
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MALDI was developed in the 1980s with the ability to ionize larger molecules like proteins and 
evolved into a tool used for bacterial identification (Singhal et al., 2015). The instruments used in 
this process contain a laser and a vertical vacuum tube with a detector at the top. Bacterial 
cultures or protein extracts are placed on a small metal plate and α-cyano-4-hydroxycinnamic 
acid (called matrix) is added. Once dry, the laser ionizes the proteins and they break away from 
the plate and rise through the vacuum to the detector. Based on the time the ionized proteins take 
to reach the top, spectral data are generated and these are compared to a library to identify the 
unknown organisms (Holland et al., 1996; Krishnamurthy and Ross, 1996). For each unknown 
isolate, a logarithmic score is generated based the amount of peaks that match and the intensity 
of those peaks (Bruker Daltonics, 2012). With a strong database, MALDI-TOF can be a valuable 
tool in bacterial identification. A 2010 reported the ability to distinguish 24 different species of 
Staphylococcus totaling over 1,000 isolates with 100% accuracy (Szabados et al., 2010). The 
initial cost of an instrument for MALDI-TOF mass spectrometry is high, but after this 
expenditure the cost per isolate can be as low as $0.43, making it a worthwhile investment for 
laboratories that can afford the instrument (Tran et al., 2015). 
MALDI-TOF has been shown to be effective for determination of Mycoplasma species in 
addition to conventional bacteria. A significant respiratory pathogen of rats and mice, 
Mycoplasma pulmonis, was shown to be accurately identified using this system, even when 
compared to similar species (Goto et al., 2012). A 2013 study showed that MALDI-TOF was 
even able to correctly distinguish between two subtypes of M. pneumoniae for all 50 isolates 
tested (Pereyre et al., 2013). While more rapid tests not requiring a culture (such as PCR) may be 
preferred, in unique circumstances MALDI-TOF may still be a better option. For example, in 
2014 MALDI-TOF was used on a clinical case to identify Mycoplasma hominis, a pathogen that 
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rarely causes brain abscesses. Ultimately, MALDI-TOF was able to quickly identify the 
pathogen and provide insight into the best treatment for the patient (Pailhories et al., 2014). 
Conclusion 
The Mollicutes are a group of bacteria that vary phenotypically and genetically from their 
more conventional prokaryotic cousins yet can still have significant impact in human medicine, 
veterinary medicine, and research. Many different species of Mycoplasma and Ureaplasma can 
cause disease in various animal hosts, and these diseases are harder to treat due to the structural 
nature of the Mollicutes. While many different identification methods exist, most require 
reagents specific to an individual species, making the diagnostic process much more expensive, 
time-consuming, and difficult. These and other methods require multiple passages of cultures to 
both isolate the organisms and then perform biochemical tests. Because of this, faster and 
cheaper tests are needed to improve the diagnostic process in order to quickly and inexpensively 
address mycoplasma issues in humans, animals, or cell culture.  
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CHAPTER 3: COMPARISON OF MALDI-TOF MASS SPECTROMETRY 
AND HIGH RESOLUTION MELTING PCR FOR THE IDENTIFICATION 
OF MYCOPLASMA BOVIS ISOLATES 
Abstract 
Mycoplasma bovis is an important pathogen of cattle worldwide. Many different clinical 
manifestations of infection can occur, including respiratory disease, arthritis, and mastitis, 
causing heavy losses to the beef and dairy industries every year. Because Mycoplasma species 
are slow-growing and fastidious, traditional identification methods are not cost or time-effective, 
and improved methods are sought to improve the diagnostic process. High resolution melting 
polymerase chain reaction (HRM-PCR) and matrix-assisted laser desorption/ionization time-of-
flight (MALDI-TOF) mass spectrometry are two relatively recent diagnostic tools that are rapid 
and inexpensive to perform, although equipment cost may be substantial. Eight field isolates and 
one reference strain of M. bovis were grown and used in both assays, followed by a comparison 
of the results. The HRM-PCR assay used universal Mycoplasma primers for the 16S-23S 
intergenic spacer region (IGSR). The resulting melt peak profiles of the field isolates were 
indistinguishable from the reference strain, indicating accurate identification. For MALDI-TOF 
mass spectrometry, each isolate was accurately identified on all replicates. Because both assays 
correctly identified all field isolates, our work shows that either assay could be used to identify 
an unknown M. bovis isolate. For future work, the MALDI-TOF library should be expanded to 
include spectra from more Mycoplasma species, and the HRM-PCR assay should be tested on 
other species of Mycoplasma to ensure that the melting profile of each species is sufficiently 
distinctive that they can be used for species differentiation. 
22 
 
Introduction 
Mycoplasma bovis is an important pathogen to the beef and dairy industries, causing 
respiratory disease, arthritis, mastitis, and other infections as well (Maunsell et al., 2011). Few 
studies of its economic impact have been conducted, but it is estimated that in the United States 
up to $32 million per year is lost by the beef industry due to reduced weight gain, and up to $108 
million per year is lost by the dairy industry because of mastitis (Maunsell et al., 2011). 
Identification of M. bovis and other Mycoplasma species in general can be an arduous task. 
While biochemical tests are the gold standard for conventional bacteria, these methods take 
weeks for the fastidious and slow-growing Mycoplasmas. In order to quickly diagnose cattle to 
prevent further spread of the infection, faster methods of identification are needed. 
Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass 
spectrometry is a tool that can be used to analyze the protein composition of bacteria (Holland et 
al., 1996; Krishnamurthy and Ross, 1996). In the last 15 years, this technology has been used to 
identify bacteria based on their protein profile created (Bernardo et al., 2002; Szabados et al., 
2010). With regards to Mycoplasma species, MALDI-TOF has been used to identify clinically 
relevant human isolates (Pereyre et al., 2013; Pailhories et al., 2014) as well as isolates from a 
few animal species, including M. bovis (Goto et al., 2012; Pereyre et al., 2013). 
Another diagnostic tool is high-resolution melting polymerase chain reaction (HRM-
PCR). This technology can be used for a variety of purposes such as genotyping and strain 
differentiation of bacteria (Gundry et al., 2003; Winchell et al., 2010; Tamburro and Ripabelli, 
2017). These applications have also been successfully implemented with viruses, fungi, and 
protists (Adaszek and Winiarczyk, 2010; Didehdar et al., 2016; Toubanaki and Karagouni, 
2017). One benefit of HRM-PCR over traditional real-time PCR for pathogen identification is 
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that one set of primers can be used to distinguish between different species or different strains of 
the same species, increasing efficiency. Depending on the target for the assay, different species 
or strains will exhibit a unique melt profile. Much of the HRM-PCR work done with 
Mycoplasma species has been with poultry isolates to distinguish between vaccine strains and 
field strains of the same species (Ghorashi et al., 2010; Ghorashi et al., 2013; Shahid et al., 
2014), though general strain differentiation work has been done as well (Jeffery et al., 2007; 
Ghorashi et al., 2015). Little HRM-PCR has been done with identification of Mycoplasma 
species, though the efficacy of such an assay using universal primers for canine, avian, and 
ruminant Mycoplasmas has been explored (Rebelo et al., 2011). 
The aim of this study was to compare the accuracy of HRM-PCR and MALDI-TOF mass 
spectrometry in the identification of M. bovis isolates for diagnostic use. Nine isolates from a 
variety of sites on the animal and locations within the United States were used along with one 
reference strain, and the results of the two assays were compared. 
Materials and Methods 
Mycoplasma bovis strains and culture 
Eight Mycoplasma bovis strains isolated at the Iowa State University Veterinary 
Diagnostic Laboratory and Jasper strain (ATCC 25025) in were used for this study (Table 3.1). 
These isolates were grown for 3-5 days in PPLO broth with horse serum (University of 
California, Davis, USA) and supplemented with 5 μg/mL cefoperazone inhibitor (Sigma-
Aldritch, USA) for the HRM-PCR. They were then subcultured onto PPLO agar with horse 
serum (University of California, Davis, USA) and grown for 3-5 days for use in MALDI-TOF 
mass spectrometry. All isolates were grown at 37° C with 7.5% CO2. 
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Table 3.1. Mycoplasma bovis isolates and their origin 
Isolate Animal Host Site of Isolation Year Isolated 
B1 Cattle Joint Fluid 2013 
B2 Cattle Ear Swab 2013 
B3 Cattle Lung 2014 
B4 Cattle Bulk Tank Milk 2014 
B5 Cattle Lung 2014 
B6 Cattle Joint Fluid 2014 
B7 Cattle Eye Swab 2015 
B8 Bison Lung 2016 
B9 (Jasper) Cattle Milk 1966 
 
DNA extraction and high-resolution melting PCR 
Genomic DNA was extracted from 200 μL of culture by boiling for 10 minutes. The cells 
were then pelleted by centrifugation in a tabletop centrifuge at 15,871 g for 3 minutes. In order to 
mimic the high-throughput environment of a diagnostic laboratory, the amount of DNA in each 
extract was not standardized. Universal primers targeting the 16S-23S intergenic spacer region 
(IGSR) were used for this assay as previously described: F 5′-ACACCATGGGAGYTGGTAAT-
3′ and R 5′-CTCCWTCGACTTYCAGACCCAAGGCAT-3′ (Rebelo et al., 2011). The Qiagen 
HRM PCR Master Mix (Qiagen, Netherlands) was used according to manufacturer’s 
recommendations with 2.5 μL of DNA extract per well. Sterile water was used in place of the 
extract for the negative amplification control, and sterile media was extracted for the negative 
extraction control. The HRM-PCR was performed on a Qiagen RotorGene Q (Qiagen, 
Netherlands) using the cycling conditions previously described (Rebelo et al., 2011). 
MALDI-TOF mass spectrometry 
After growing for approximately 3-5 days, the M. bovis isolates were run in MALDI-
TOF. For each strain, whole cells were spotted four times onto a single steel target and run 
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according to the manufacturer’s recommendations (Bruker, Germany). The result is expressed as 
a logarithmic score ranging from 0 to 3 with a score of ≥2.0 considered acceptable for 
identification, and this score is based on the number of peaks that match along with their 
intensity (Bruker Daltonics, 2012). 
16S-23S IGSR sequence analysis and statistics 
Using the whole genome sequence available in GenBank under accession number 
CP002188, the sequences of the two 16S-23S intergenic spacer regions were analyzed. These 
311 bp sequences were aligned via BLASTn to observe differences in the sequences. Dunnett’s 
test for multiple comparisons was used to compare the melting temperatures of the field isolates 
to those of the reference strain for the HRM-PCR assay. MALDI-TOF mass spectrometry data 
was analyzed using a one-way ANOVA with Tukey’s multiple comparison test. 
Results 
All of the nine Mycoplasma bovis isolates exhibited two melt peaks: the first at 76.25 ± 
0.005° C and the second at approximately 80.94 ± 0.008° C. Additionally, the height of the 
second peak was one-third the height of the first peak (Figure 3.1). No significant difference 
between the melting temperatures was present when comparing the field strains to the reference 
strain for either the first peak or the second peak (Table 3.2). Every isolate was correctly 
identified as Mycoplasma bovis by the MALDI-TOF software, though the top scores ranged from 
1.71 to 2.39. The Jasper reference strain had the highest score values, but it was only 
significantly higher than two of the eight field strains (Figure 3.2). 
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Figure 3.1. Identification of Mycoplasma bovis isolates by high-resolution melting PCR. HRM-PCR was 
done in triplicate for each isolate. The PCR threshold was determined automatically by the Qiagen Rotor-
Gene Q Series Software. 
 
 
Table 3.2. Mean melt peak temperatures* for 
Mycoplasma bovis isolates  
Isolate Mean Temperature (° C) 
Peak 1 Peak 2 
B1 76.255 ± 0.001 80.941 ± 0.001 
B2 76.259 ± 0.005 80.950 ± 0.008 
B3 76.257 ± 0.004 80.930 ± 0.005 
B4 76.251 ± 0.003 80.940 ± 0 
B5 76.256 ± 0.002 80.938 ± 0.002 
B6 76.253 ± 0.002 80.945 ± 0.003 
B7 76.251 ± 0.001 80.933 ± 0.001 
B8 76.245 ± 0.001 80.937 ± 0.002 
B9 76.249 ± 0.001 80.937 ± 0.001 
* Data represents the mean of the three replicates 
± SE. 
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Figure 3.2. Mean MALDI-TOF score for each 
Mycoplasma bovis isolate. Dunnett’s test was 
performed comparing the field isolates to B9 (grey), 
the reference strain. An asterisk indicates a p-value 
<0.05. 
 
Discussion 
In the HRM-PCR assay, two melting peaks were present for each M. bovis isolate, at 
temperatures consistent with previous findings for this assay (Rebelo et al., 2011). One possible 
explanation is that the M. bovis genome contains two copies of the rRNA genes, and if the 
sequences vary sufficiently, they could have resulted in different melting temperatures (TM) 
(Wise et al., 2011). When comparing the DNA sequences of the two 16S-23S IGSR of the M. 
bovis PG45 genome, the sequences are almost identical, with only two deletions and one single 
nucleotide polymorphism in the second copy compared to the first copy. This would likely not be 
enough to change the TM by almost five degrees, and even if it would, the brightness of the two 
peaks would be approximately equal as the two 16S-23S IGSR sequences are both 311 bp in 
length (Wise et al., 2011). An alternative explanation for the presence of two peaks is that the 
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sequences have two regions with significantly different GC content, resulting in a partial melt 
followed by a complete melt at a higher temperature. This second explanation seems to be more 
likely, as the second, higher TM (80.94° C) of each isolate was less fluorescent, indicating that 
less dye was released and so less DNA remained to melt. 
The MALDI-TOF scores for the reference strain of M. bovis tended to be higher than at 
least some of the field strains. This was expected, as spectra for that exact strain are present in 
the MALDI-TOF library used. While each organism was identified correctly by the MALDI-
TOF software, the library used did not include a large number of Mycoplasma species. Spectra 
from only ten species other than M. bovis were present, and none of these were from closely 
related species such as M. agalactiae, M. californicum, or M. fermentans (Mattsson et al., 1994; 
Pettersson et al., 1996). Many of the scores were also between 1.7 and 2.0, indicating that the top 
scoring organism may not be acceptable for species-level identification, though other 
investigators have determined that scores above a 1.7 may be sufficient for certain Mycoplasma 
species including M. bovis (Pereyre et al., 2013). Without the addition of spectra of more closely 
related species, however, it is not possible to determine if the spectra for M. bovis in the present 
library are sufficient for consistent, accurate identification. 
The two methods that were explored both resulted in accurate identification 100% of the 
time. The HRM-PCR assay found no difference between the melting peaks of the field isolates 
and the reference strain, and all replicates of all isolates in MALDI-TOF resulted in scores of 1.7 
or greater. Both assays can be completed within just a few hours and, if using validated, 
universal primers for the HRM-PCR, both assays could be used for many different species, 
making them overall much less expensive than a separate assay for each individual organism. 
These tools are testing different aspects of the genetic code, however, and depending on the 
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circumstance, one test may be preferred. MALDI-TOF creates spectra from the proteins of the 
cultures while HRM-PCR generates a melt curve profile from the DNA. MALDI-TOF would 
find no difference between two isolates with varying silent mutations, as these do not affect the 
encoded amino acids, and for identification purposes, this would be preferred. As new, variant 
isolates of a species are discovered, additional spectra can be added to the database to improve 
its diagnostic capabilities. HRM-PCR relies on only one isolate per species as a control whereas 
MALDI-TOF needs spectra from multiple isolates of a species in order to get a well-rounded 
library of spectra of a given species. If the target sequence varies too much with a given species, 
however, HRM-PCR will not be able to identify that organism, and so the PCR targets must be 
extremely well-validated. 
In the future, other organisms should be explored for the HRM-PCR assay to confirm that 
between Mycoplasma species the melt curve profile generated is unique, but within species it is 
the same. Additionally, the potential use of HRM-PCR directly of tissue samples should be 
investigated, as this would drastically decrease the time and cost required for identification. For 
MALDI-TOF, the library should be expanded to include spectra from many more Mycoplasma 
species, including those that are closely related and therefore might have similar protein profiles. 
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CHAPTER 4: COMPARISON OF TWO HIGH-RESOLUTION MELTING 
PCR ASSAYS FOR THE IDENTIFICATION OF MYCOPLASMA SPECIES 
Abstract 
Mycoplasma and Ureaplasma species are significant veterinary pathogens, causing 
significant losses to producers of swine, cattle, and poultry every year. More rapid and 
inexpensive diagnostic tests are needed for these organisms in order to more quickly treat 
affected animals and prevent further losses. A high-resolution melting polymerase chain reaction 
(HRM-PCR) assay for the identification of unknown Mycoplasma species was developed and 
compared to a previously described assay. Nine different species were used in these assays: 
Mycoplasma bovis, Mycoplasma canis, Mycoplasma hyorhinis, Mycoplasma hyosynoviae, 
Mycoplasma hyopneumoniae, Mycoplasma gallisepticum, Mycoplasma flocculare, Mycoplasma 
synoviae, and Ureaplasma diversum, six of which had field strains in addition to the reference 
strains. The previously developed assay was able to accurately identify all isolates of M. bovis 
and M. hyopneumoniae, but only some isolates of the other organisms. It also did not amplify M. 
gallisepticum or U. diversum. The new assay identified all isolates of M. bovis, M. 
hyopneumoniae, and M. canis and most M. hyorhinis, but only some of the M. hyosynoviae and 
none of the M. gallisepticum. While HRM-PCR is a promising tool for identification of unknown 
isolates, exploration of many more species and alternative targets may be necessary for 
consistent, accurate results. 
Introduction 
Mycoplasma and Ureaplasma species, often simply Mycoplasmas, are significant 
veterinary pathogens, costing producers millions of dollars every year (Mohammed et al., 1987; 
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Maunsell et al., 2011; Holtkamp, 2014). These organisms are different from most bacteria in that 
they completely lack a cell wall. This defining feature also makes the resulting infections much 
more difficult to treat, as many common antibiotics target the cell wall of bacteria and so these 
will be ineffective against mycoplasmal infections (Razin, 1983). Because these bacteria are 
more difficult to treat, a fast diagnosis is key in order to provide the right treatments to infected 
animals. Mycoplasmas are slow-growing and fastidious organisms, however, some taking as 
long as 40 days to culture (Jensen et al., 1996). Traditional biochemical tests usually require two 
culturing steps, and so these take too long in a diagnostic setting (Goll, 1994). Additionally, 
while molecular assays such as polymerase chain reaction (PCR) are rapid, they are generally 
species-specific, and so multiple different tests are needed to identify unknown isolates, greatly 
increasing costs. 
High-resolution melting PCR (HRM-PCR) is a recent diagnostic tool that functions like 
traditional real-time PCR, but has an extra melt step at the end. Additionally, less-biased 
fluorescent dyes are used in HRM-PCR in order to more accurately determine the melting point 
of the DNA amplicon (Taylor et al., 2010). After the assay is complete, a melt curve profile is 
generated for each PCR amplicon and serves as the defining feature of the assay. HRM-PCR has 
a very wide range of applications, from genotyping and single nucleotide polymorphism analysis 
to pathogen identification and characterization (Winchell et al., 2010; Tamburro and Ripabelli, 
2017). For Mycoplasma species, HRM-PCR has been used for a few select purposes. 
Differentiating between vaccine strains and field strains has been explored primarily with poultry 
pathogens (Ghorashi et al., 2013; Shahid et al., 2014; Zhu et al., 2017). HRM-PCR has also been 
used as a tool for discrimination between different species of Mycoplasma and as a potential tool 
for identification (Rebelo et al., 2011; Al-Farha et al., 2018). 
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The aim of this study was to develop an HRM-PCR assay using universal primers for 
Mycoplasma and Ureaplasma species and compare this to a previously developed assay for the 
identification of unknown isolates. As each species would result in its own unique melt curve 
profile, an unknown isolate with the same as a control species would reveal its identity. 
Materials and Methods 
Strains 
Eight different Mycoplasma and one Ureaplasma species were used in the HRM-PCR 
assays (Table 4.1). For each organism, one reference strain was used and for Mycoplasma 
hyopneumoniae, Mycoplasma hyorhinis, Mycoplasma hyosynoviae, Mycoplasma bovis, 
Mycoplasma canis, and Mycoplasma gallisepticum, field strains were also utilized, most 
originating from the Iowa State University Veterinary Diagnostic Laboratory (Table 4.2). 
Media and Culture 
Mycoplasma bovis and M. canis isolates were grown in PPLO broth with horse serum 
(University of California-Davis) for 3-5 days with 7.5% CO2. The M. gallisepticum isolates were 
grown in Hayflicks broth (University of California-Davis) for 5-7 days with 7.5% CO2. The M. 
hyopneumoniae, M. hyorhinis, and Mycoplasma flocculare isolates were grown in Friis broth 
with tight caps for 3-7 days. For the M. hyosynoviae isolates, PPLO broth with turkey serum and 
mucin (ThermoFisher Scientific, USA) was used, and these were grown with tight caps for 3-5 
days. The M. synoviae strain was grown in PPLO broth with horse serum and NAD 
(ThermoFisher Scientific, USA) for 3-5 days with 7.5% CO2. Lastly, the Ureaplasma diversum 
strain was grown in PPLO broth with horse serum and urea (ThermoFisher Scientific, USA) for 
5-7 days. All isolates were cultured at 37° C. 
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Table 4.1. Mycoplasma and Ureaplasma species used and their associated diseases 
Organism Animal Hosts Associated Infections and Conditions 
Mycoplasma hyopneumoniae Swine Porcine enzootic pneumonia (Maes et al., 
2018) 
Mycoplasma hyorhinis Swine Arthritis, lameness, polyserositis (Wilberts et 
al., 2015) 
Mycoplasma hyosynoviae Swine Arthritis, lameness (Wilberts et al., 2015) 
Mycoplasma flocculare Swine None (Calcutt et al., 2015) 
Mycoplasma bovis Cattle 
 
 
Bison 
Respiratory disease, arthritis, mastitis, 
conjunctivitis, otitis media (Maunsell et al., 
2011) 
Respiratory disease, lameness, mastitis 
(Janardhan et al., 2010) 
Mycoplasma canis Dogs 
 
 
Cattle 
Urogenital disease, meningoencephalitis 
(L'Abee-Lund et al., 2003; Michaels et al., 
2016) 
Respiratory disease (Thomas et al., 2002) 
Mycoplasma gallisepticum Chickens 
 
Turkeys 
Finches 
Chronic respiratory disease (Nascimento et 
al., 2005) 
Infectious sinusitis (Nascimento et al., 2005) 
Conjunctivitis (Luttrell et al., 1998) 
Mycoplasma synoviae Chickens 
Turkeys 
Infectious synovitis (Nascimento et al., 2005) 
Infectious synovitis (Nascimento et al., 2005) 
Ureaplasma diversum Cattle Endometritis, infertility, abortion, weak calf 
syndrome (Mulira et al., 1992) 
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Table 4.2. Collected strains and their site of origin 
Species Organism ID Animal Host Specimen 
Mycoplasma bovis ATCC 25523 Cattle Milk 
          M. bovis B1 Cattle Joint 
          M. bovis B2 Cattle Ear 
          M. bovis B3 Cattle Lung 
          M. bovis B4 Cattle Milk 
          M. bovis B5 Cattle Lung 
          M. bovis B6 Cattle Joint 
          M. bovis B7 Cattle Eye 
          M. bovis B8 Bison Lung 
          M. bovis B9 Cattle Milk 
Mycoplasma canis ATCC 19525 Dog Throat 
          M. canis C1 Dog BAL 
          M. canis C3 Dog BAL 
          M. canis C5 Dog Unknown 
Mycoplasma hyorhinis ATCC 17981 Swine Nose 
          M. hyorhinis R1 Swine Nose 
          M. hyorhinis R2 Swine Spleen 
          M. hyorhinis R4 Swine Lung 
          M. hyorhinis R5 Swine Lung 
          M. hyorhinis R6 Swine Lung 
          M. hyorhinis R7 Swine Eye 
          M. hyorhinis R8 Swine Fibrin 
          M. hyorhinis R9 Swine Fibrin 
Mycoplasma hyosynoviae ATCC 25591 Swine Joint 
          M. hyosynoviae S1 Swine Joint 
          M. hyosynoviae S2 Swine Joint 
          M. hyosynoviae S3 Swine Joint 
          M. hyosynoviae S4 Swine Joint 
          M. hyosynoviae S5 Swine Joint 
          M. hyosynoviae S6 Swine Joint 
          M. hyosynoviae S8 Swine Eye 
          M. hyosynoviae S9 Swine Joint 
Mycoplasma hyopneumoniae ATCC 25934 Swine Lung 
          M. hyopneumoniae P1 Swine Lung 
          M. hyopneumoniae P2 Swine Lung 
          M. hyopneumoniae P3 Swine BAL 
          M. hyopneumoniae P4 Swine Lung 
Mycoplasma flocculare ATCC 27399 Swine Lung 
Mycoplasma gallisepticum ATCC 19610 Chicken Trachea/Airsac 
          M. gallisepticum G1 House Finch Eye 
          M. gallisepticum G2 House Finch Eye 
          M. gallisepticum G3 House Finch Eye 
Mycoplasma synoviae ATCC 25204 Chicken Joint 
Ureaplasma diversum ATCC 43321 Cattle Lung 
 
DNA Extraction and HRM-PCR-1 
Magnetic bead DNA extraction was performed on a KingFisher Flex Purification System 
(ThermoFisher Scientific, USA) using 50 μL of each culture, with sterile media serving as a 
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negative extraction control. For the HRM-PCR assay previously developed (HRM-PCR-1), the 
two primers used targeted the 16S-23S intergenic spacer region (IGSR) and were: F 5′-
ACACCATGGGAGYTGGTAAT-3′ and R 5′-CTCCWTCGACTTYCAGACCCAAGGCAT-3′. 
The Qiagen HRM PCR Master Mix (Qiagen, Netherlands) was used with 0.5 μM of the forward 
and reverse primers. To each well, 22.5 μL of the complete master mix and 2.5 μL of DNA 
extract was added. Sterile water was used in place of the extract for the negative amplification 
control. The HRM-PCR-1 assay was performed on a Qiagen RotorGene Q (Qiagen, Netherlands) 
in duplicate using the cycling conditions previously described (Rebelo et al., 2011). 
HRM-PCR-2 
For the newly developed HRM-PCR assay (HRM-PCR-2), DNA was extracted as above, 
and the PCR master mix was prepared as HRM-PCR-1 but with different primers. The new 
primers were: F 5’-CCTACGAGAACGTCGGGRT-3’ and R 5’-
AGACCCAAGGCATCCACYA-3’. In development of HRM-PCR-2, the reference strains were 
run in triplicate on the same instrument as HRM-PCR-1 with the following cycling conditions: 
95° C for 5 min, followed by 40 cycles of 94° C for 30 sec, 53° C for 30 sec, and 72° C for 60 
sec, then 72° C for 10 min, 95° C for 60 sec, and 40° C for 60 sec. The HRM analysis 
immediately followed the PCR and consisted of a melt from 60° C to 95° C rising 0.05° C/sec. 
To test the field strains, all cultures, including the reference strains, were run in duplicate 
following the same conditions as above. 
Analysis and Statistics 
Following PCR, the products for all M. hyosynoviae and M. gallisepticum strains were 
sequenced by Sanger sequencing. The sequences were analyzed using DNASTAR Lasergene 13 
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and MEGA X. HRM-PCR-2 data was analyzed using the Qiagen Rotor-Gene Q Series Software 
(Qiagen, Netherlands). For the HRM analysis, M. bovis was chosen as the normalization 
organism, comparing all other melt curve profiles to the M. bovis profile. The HRM-PCR-2 melt 
peaks of the reference strains were first compared to each other using a one-way ANOVA with 
Tukey’s multiple comparison test. Then for both HRM-PCR-1 and HRM-PCR-2, melt peaks 
from each field isolate were compared to those of each control also using a one-way ANOVA 
with Tukey’s multiple comparison test. 
Results 
In HRM-PCR-1, each isolate gave two or three melt peaks ranging from about 72.6° C to 
82.5° C (Table 4.3). Two species, M. gallisepticum and U. diversum, did not amplify with this 
assay at all. The melt peak temperatures of each respective peak (first, second, third) were 
compared between the reference strains and field strains. Of the field isolates tested, all M. bovis 
and M. hyopneumoniae strains were correctly identified, and 2/3 M. canis, 2/8 M. hyorhinis, and 
3/8 M. hyosynoviae strains were correctly identified. The HRM analysis showed distinct 
differences between standards but was not able to further identify field isolates (Figure 1A). 
For the HRM-PCR-2 assay with the reference strains, each species gave one to three 
peaks with melt temperatures ranging from approximately 72.3° C to 76.4° C (Table 4.3). For the 
statistical analysis, data from each species’ first peak was compared followed by a comparison of 
data from the second peak. No analysis was done on third peaks, as only M. hyopneumoniae had 
a third peak. All of the first peaks were significantly different from each other (p  < 0.05) except 
for M. hyorhinis and U. diversum. For the second peaks, only M. hyorhinis and M. gallisepticum 
were not significantly different. The difference curve of the HRM analysis showed distinct 
differences between each of the species tested (Figure 4.1B). When comparing just the melting 
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temperatures of the field strains, many of the isolates were not correctly identified by one peak 
alone. When taking into account all peaks and the melting temperatures of the peaks, however, 
all M. bovis and M. hyopneumoniae isolates were correctly identified. With the addition of the 
HRM analysis, 7/8 M. hyorhinis isolates, all M. canis isolates, and 2/8 M. hyosynoviae isolates 
were identified correctly. None of the M. gallisepticum field isolates were correctly identified 
with this HRM-PCR assay (Table 4.4). 
 
Table 4.3. Melt peak temperatures* of the reference strains  
Reference Species HRM-PCR-1 TM HRM-PCR-2 TM 
Peak 1 Peak 2 Peak 3 Peak 1 Peak 2 Peak 3 
M. bovis 75.73 ± 
0.010° C 
80.92 ± 
0.025° C 
– 75.58 ± 
0.020° C 
– – 
M. canis 75.80 ± 
0.013° C 
82.51 ± 
0.005° C 
– 75.05 ± 
0° C 
75.41 ± 
0.003° C 
– 
M. hyorhinis 74.24 ± 
0° C 
81.95 ± 
0.005° C 
– 73.94 ± 
0.008° C 
76.21 ± 
0.005° C 
– 
M. hyosynoviae 76.01 ± 
0.028° C  
82.22 ± 
0.025° C  
– 75.76 ± 
0.028° C  
– – 
M. hyopneumoniae 72.68 ± 
0° C 
74.66 ± 
0.008° C 
82.24 ± 
0.003° C 
72.8 ± 
0.010° C 
74.22 ± 
0.030° C 
75.70 ± 
0.025° C 
M. flocculare 74.22 ± 
0.020° C 
82.51 ± 
0.013° C 
– 73.33 ± 
0.005° C 
– – 
M. gallisepticum – – – 74.24 ± 
0° C 
76.21 ± 
0° C 
– 
M. synoviae 74.60 ± 
0.010° C 
77.96 ± 
0.003° C 
82.56 ± 
0.008° C 
74.53 ± 
0.008° C 
76.83 ± 
0.043° C 
– 
U. diversum – – – 73.99 ± 
0.013° C 
75.02 ± 
0° C 
– 
* Melt peak temperatures were done in duplicate. Data represents mean temperature ± 
SE. A dash indicates that no peak was present. 
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Figure 4.1. Difference curve for the high-resolution melt analyses of Mycoplasma 
and Ureaplasma reference strains. The difference curves for both HRM-PCR-1 
(A) and HRM-PCR-2 (B) were generated using M. bovis as the fluorescence 
baseline. 
 
The sequence analysis of the M. gallisepticum isolates showed that while the three field 
isolates were nearly identical, the reference strain had 12 single nucleotide polymorphisms 
(SNPs) and a 4 bp insertion throughout the 705 bp region, compared to the field isolates. The 
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sequence analysis of the M. hyosynoviae isolates showed only 7 SNPs throughout the 270 bp 
region, though these did not appear to be restricted to the reference strain. Generation of a 
maximum-likelihood phylogenetic tree showed that there were four distinct sequence groups for 
the field isolates with the reference strain in a fifth group (Figure 4.2). 
Discussion 
Of the five species of field isolates that amplified in the HRM-PCR-1 assay, only two 
were identified with 100% accuracy. Only seven of the nine species tested were amplified in this 
assay, though one of those that did not amplify was a Ureaplasma species and the primers were 
not designed with those in mind. The assay was originally developed for use with Mycoplasma 
species of ruminant, canine, and avian hosts, but the PCR did not work with M. gallisepticum, an 
important avian pathogen (Rebelo et al., 2011).  
As expected, the reference strains of all nine species each gave a distinct melt curve 
profile in the HRM-PCR-2 assay. Additionally, this assay was able to correctly identify all of the 
M. bovis and M. hyopneumoniae isolates and most of the M. hyorhinis and M. canis isolates. 
Only 25% of the M. hyosynoviae isolates were correctly identified, and none of the M. 
gallisepticum isolates were correctly identified. The one M. hyorhinis strain that did not correctly 
identify was isolated from the eye of a pig. It has been shown that some M. hyorhinis strains that 
are associated with conjunctivitis vary serologically compared to other strains of M. hyorhinis, 
and so it is possible that the unidentifiable isolate lies within this subgroup (Friis, 1976). 
Alternatively, one strain of M. bovis was isolated from a bison, and it has been shown that 
isolates from bison and cattle are also genetically distinct (Register et al., 2015). 
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Table 4.4. High-resolution melt analysis identification result  
Organism ID Isolate HRM-PCR-1 ID HRM-PCR-2 ID 
B1 M. bovis M. bovis M. bovis 
B2 M. bovis M. bovis M. bovis 
B3 M. bovis M. bovis M. bovis 
B4 M. bovis M. bovis M. bovis 
B5 M. bovis M. bovis M. bovis 
B6 M. bovis M. bovis M. bovis 
B7 M. bovis M. bovis M. bovis 
B8 M. bovis M. bovis M. bovis 
B9 M. bovis M. bovis M. bovis 
C1 M. canis M. canis M. canis 
C3 M. canis None* M. canis 
C5 M. canis M. canis M. canis 
R1 M. hyorhinis None M. hyorhinis 
R2 M. hyorhinis M. hyorhinis M. hyorhinis 
R4 M. hyorhinis None M. hyorhinis 
R5 M. hyorhinis None M. hyorhinis 
R6 M. hyorhinis None M. hyorhinis 
R7 M. hyorhinis M. hyorhinis None 
R8 M. hyorhinis None M. hyorhinis 
R9 M. hyorhinis None M. hyorhinis 
S1 M. hyosynoviae M. hyosynoviae M. hyosynoviae 
S2 M. hyosynoviae None None 
S3 M. hyosynoviae M. hyosynoviae M. hyosynoviae 
S4 M. hyosynoviae None None 
S5 M. hyosynoviae None None 
S6 M. hyosynoviae None None 
S8 M. hyosynoviae M. hyosynoviae None 
S9 M. hyosynoviae None None 
P1 M. hyopneumoniae M. hyopneumoniae M. hyopneumoniae 
P2 M. hyopneumoniae M. hyopneumoniae M. hyopneumoniae 
P3 M. hyopneumoniae M. hyopneumoniae M. hyopneumoniae 
P4 M. hyopneumoniae M. hyopneumoniae M. hyopneumoniae 
G1 M. gallisepticum N/A None 
G2 M. gallisepticum N/A None 
G3 M. gallisepticum N/A None 
* Isolates without an ID did not have melt peaks or a melt curve profile that 
matched a reference strain. 
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Figure 4.2. Maximum-likelihood phylogenetic tree of M. hyosynoviae strains 
based on 16S-23S rRNA intergenic spacer region. Phylogenetic tree generated in 
MEGA X software. 
 
None of the three M. gallisepticum isolates were correctly identified using this method, 
however all three isolates originated from house finches while the reference strain originated 
from a chicken. The melt curve profiles of these three house finch isolates were indistinguishable 
from each other. This indicates that house finch isolates may be members of a separate group of 
M. gallisepticum, as was seen in the sequencing of the PCR products. This reasoning is 
supported by previous phylogenetic studies that have shown that M. gallisepticum isolates from 
house finches are distinct from isolates from poultry (Delaney et al., 2012). The M. hyosynoviae 
isolates also identified poorly. Sequencing results indicated that there were SNPs throughout the 
sequences, accounting for 2.6% of differences compared to 1.7% with M. gallisepticum. The 
phylogenetic tree separated the M. hyosynoviae isolates into five groups. Interestingly, when 
comparing the HRM data of the field strains to each other as opposed to the reference strain, 
isolate S1 was significantly different from S2 and S9 with no other significant differences, 
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differing from the groupings of the sequence data. Most likely this is due to differences in 
calculations, as the HRM identification has a range of acceptable statistical difference whereas 
the phylogenetic tree considers every individual nucleotide difference. Some subgroups within a 
species may only require a single control, while other subgroups within a species may not 
identify correctly using this method without a separate reference strain for that subgroup. 
The two HRM-PCR assays were both able to correctly identify the M. bovis and M. 
hyopneumoniae isolates. Those two species have the greatest clinical disease implications of 
Mycoplasma species of their respective hosts, however other significant pathogens were not 
properly identified. The newly developed assay was able to identify most M. hyorhinis isolates, 
however neither assay was able to identify the M. hyosynoviae isolates. This suggests that the 
16S-23S IGSR of M. hyosynoviae is not well conserved between species. It is worth noting, 
however, that while these isolates could not be confirmed as M. hyosynoviae, they were not 
misidentified as another species. The second assay also gave different melt curve profiles for 
each species. All of the isolates in HRM-PCR-1 had at least two melt peaks, while one-third of 
the species had only one peak in HRM-PCR-2. While the two assays produced amplicons of 
similar size, the slight differences in sequence were enough to cause drastic changes in the melt 
curve profiles of the organisms. 
The HRM-PCR-2 assay worked on all nine species tested, while the HRM-PCR-1 assay 
did not, indicating that the former can be used on a wider array of species. While neither assay 
was able to accurately identify all isolates, the HRM-PCR-2 assay worked correctly for most and 
so shows the most promise as a diagnostic tool for identification of unknown isolates. Future 
work should look at a much wider variety of species and include field isolates for each of those 
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to ensure the homogeneity of melt curves within species. Additionally targets other than the 16S-
23S IGSR should be explored for use in an HRM-PCR assay. 
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CHAPTER 5: GENERAL CONCLUSIONS 
MALDI-TOF mass spectrometry and HRM-PCR are two tools that have been shown to 
provide rapid, inexpensive, and accurate diagnosis for various pathogens. For Mycoplasma 
infections, this is key in order to apply the proper treatment regimen. The purpose of these 
studies was to determine which assay, if any, was superior, and then further explore the use of 
HRM-PCR as a tool for identification of Mycoplasma and Ureaplasma species. 
When comparing MALDI-TOF with HRM-PCR, both assays were able to accurately and 
consistently identify Mycoplasma bovis. As neither assay was superior, it was determined that 
either could be used for that single species. The two HRM-PCR assays were both able to identify 
some species, however the new assay appeared to be superior. Neither assay was able to 
accurately identify all species tested, however. HRM-PCR-2 was unable to identify isolates that 
may be members of subgroups within their species. Only a few isolates of Mycoplasma 
hyosynoviae were properly identified, and these isolates were not known to be members of any 
subgroup, suggesting that perhaps alternative targets might prove superior to the 16S-23S IGSR 
for an HRM-PCR assay for swine specimens. As three of the species tested had only one isolate 
(the reference strain), the effectiveness of HRM-PCR on these species cannot be determined, 
only that other species are not misidentified as them. Additionally, more field isolates of the 
various species need to be included to fully evaluate the effectiveness of the HRM-PCR. 
Because both types of identification assays tested require libraries of known positives for 
comparison, additional species are needed to ensure that false identification does not occur. 
Future work should focus on expanding the library of spectra for MALDI-TOF to include a 
broader range of Mycoplasma species. Work with HRM-PCR should explore other conserved 
regions amongst Mycoplasma species in order to find better targets, and more isolates of more 
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species should be tested with the new 16S-23S IGSR primers to confirm the specificity of the 
melt curve profiles. In addition, the use of HRM-PCR directly on tissue samples should be 
explored in order to reduce time and costs. 
 
 
 
